Cargando…
Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα
Cholestasis is caused by intrahepatic retention of excessive toxic bile acids and ultimately results in hepatic failure. Da-Chai-Hu-Tang (DCHT) has been used in China to treat liver and gallbladder diseases for over 1800 years. Here, we demonstrated that DCHT treatment prevented acute intrahepatic c...
Autores principales: | Xu, Shihao, Qiao, Xi, Peng, Peike, Zhu, Ziyi, Li, Yaoting, Yu, Mengyuan, Chen, Long, Cai, Yin, Xu, Jin, Shi, Xinwei, Proud, Christopher G., Xie, Jianling, Shen, Kaikai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965327/ https://www.ncbi.nlm.nih.gov/pubmed/35370715 http://dx.doi.org/10.3389/fphar.2022.847483 |
Ejemplares similares
-
Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis
por: Zhou, YueHua, et al.
Publicado: (2022) -
Current Understanding on Antihepatocarcinoma Effects of Xiao Chai Hu Tang and Its Constituents
por: Zheng, Ningning, et al.
Publicado: (2013) -
Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model
por: ZHENG, CHUN-SONG, et al.
Publicado: (2014) -
Renal Protective Effect of Xiao-Chai-Hu-Tang on Diabetic Nephropathy of Type 1-Diabetic Mice
por: Lin, Chun-Ching, et al.
Publicado: (2012) -
Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang
por: Jin, Jingyun, et al.
Publicado: (2021)